Guangyi Jin

1.5k total citations
48 papers, 1.2k citations indexed

About

Guangyi Jin is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Guangyi Jin has authored 48 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 24 papers in Molecular Biology and 16 papers in Oncology. Recurrent topics in Guangyi Jin's work include Immune Response and Inflammation (18 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (8 papers). Guangyi Jin is often cited by papers focused on Immune Response and Inflammation (18 papers), Immunotherapy and Immune Responses (13 papers) and Immune Cell Function and Interaction (8 papers). Guangyi Jin collaborates with scholars based in China, United States and Germany. Guangyi Jin's co-authors include Ming-Hao Hu, Boris Illarionov, Markus Fischer, Adelbert Bacher, Howard B. Cottam, Dennis A. Carson, Qiong Huang, Ou Sha, Zhulin Wang and Chunman Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Biochemistry.

In The Last Decade

Guangyi Jin

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guangyi Jin China 20 606 383 243 165 105 48 1.2k
Huan Nie China 22 801 1.3× 322 0.8× 149 0.6× 107 0.6× 64 0.6× 56 1.4k
Joanna Rossowska Poland 21 357 0.6× 353 0.9× 230 0.9× 65 0.4× 99 0.9× 60 1.2k
Somesh Sharma India 22 648 1.1× 233 0.6× 235 1.0× 169 1.0× 65 0.6× 62 1.4k
Hanjie Yu China 20 923 1.5× 360 0.9× 122 0.5× 152 0.9× 38 0.4× 82 1.4k
Danuta Duś Poland 23 776 1.3× 327 0.9× 378 1.6× 205 1.2× 54 0.5× 106 1.5k
Salvatore Di Maro Italy 25 755 1.2× 164 0.4× 260 1.1× 227 1.4× 32 0.3× 63 1.3k
Renée Mosi Canada 14 411 0.7× 164 0.4× 370 1.5× 262 1.6× 103 1.0× 18 1.1k
Stefanie C. Fas Germany 14 665 1.1× 386 1.0× 181 0.7× 58 0.4× 96 0.9× 15 1.3k
Iva Ugrinova Bulgaria 21 825 1.4× 214 0.6× 188 0.8× 106 0.6× 106 1.0× 65 1.5k
Srujan Marepally India 20 717 1.2× 214 0.6× 97 0.4× 66 0.4× 78 0.7× 60 1.3k

Countries citing papers authored by Guangyi Jin

Since Specialization
Citations

This map shows the geographic impact of Guangyi Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyi Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyi Jin more than expected).

Fields of papers citing papers by Guangyi Jin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guangyi Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyi Jin. The network helps show where Guangyi Jin may publish in the future.

Co-authorship network of co-authors of Guangyi Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Guangyi Jin. A scholar is included among the top collaborators of Guangyi Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyi Jin. Guangyi Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jiaxin, et al.. (2024). Combination Therapy with a TLR7 Agonist and a BRD4 Inhibitor Suppresses Tumor Growth via Enhanced Immunomodulation. International Journal of Molecular Sciences. 25(1). 663–663.
2.
Zhao, Weiqiang, Yisheng Li, Guangyi Jin, et al.. (2022). MAGEA1 and hTERT Peptide Treatment Improves the Potency of The Dendritic Cell- Cytotoxic T Lymphocytes (DC-CTL) Immunotherapy in DAC Treated Acute Myeloid Leukemia. Journal of Cancer. 13(4). 1252–1260. 4 indexed citations
3.
Ren, Sumei, Xiaodong Wang, Jun Song, & Guangyi Jin. (2021). Discovery of novel ibrutinib analogues to treat malignant melanoma. Bioorganic Chemistry. 117. 105419–105419. 4 indexed citations
4.
5.
Hu, Ming-Hao, et al.. (2020). Drug-like biimidazole derivatives dually target c-MYC/BCL-2 G-quadruplexes and inhibit acute myeloid leukemia. Bioorganic Chemistry. 104. 104264–104264. 14 indexed citations
6.
7.
Hu, Yunlong, Zhengyu Zhu, He Meng, et al.. (2020). A novel TLR7 agonist as adjuvant to stimulate high quality HBsAg-specific immune responses in an HBV mouse model. Journal of Translational Medicine. 18(1). 112–112. 19 indexed citations
8.
Wang, Jiali, Shiyang Zhou, Xinxin Luo, et al.. (2018). Cinobufacini protects against paclitaxel-induced peripheral neuropathic pain and suppresses TRPV1 up-regulation and spinal astrocyte activation in rats. Biomedicine & Pharmacotherapy. 108. 76–84. 43 indexed citations
9.
Wang, Xiaodong, et al.. (2018). Gastric cancer vaccines synthesized using a TLR7 agonist and their synergistic antitumor effects with 5-fluorouracil. Journal of Translational Medicine. 16(1). 120–120. 25 indexed citations
10.
Li, Chunman, et al.. (2017). Anti-tumor Activity of Toll-Like Receptor 7 Agonists. Frontiers in Pharmacology. 8. 304–304. 137 indexed citations
11.
Gao, Ningning, Xiaodong Wang, Wang Li, et al.. (2016). Immunomodulatory and Antitumor Effects of a Novel TLR7 Agonist Combined with Lapatinib. Scientific Reports. 6(1). 39598–39598. 6 indexed citations
12.
Du, Yongkun, Taofeng Du, Angke Zhang, et al.. (2016). Synthetic Toll-like receptor 7 ligand inhibits porcine reproductive and respiratory syndrome virus infection in primary porcine alveolar macrophages. Antiviral Research. 131. 9–18. 21 indexed citations
13.
Lin, Guimiao, Xiaomei Wang, Chuanxia Zhang, et al.. (2015). A conjugate of octamer-binding transcription factor 4 and toll-like receptor 7 agonist prevents the growth and metastasis of testis embryonic carcinoma. Journal of Translational Medicine. 13(1). 166–166. 12 indexed citations
14.
Wang, Xiaodong, et al.. (2015). Synergistic apoptosis-inducing effect of aspirin and isosorbide mononitrate on human colon cancer cells. Molecular Medicine Reports. 12(3). 4750–4758. 15 indexed citations
15.
Chen, Tingting, Yunlong Hu, Xiaotan Lin, et al.. (2015). Dopamine signaling regulates the projection patterns in the mouse chiasm. Brain Research. 1625. 324–336. 6 indexed citations
16.
Gao, Dong, Wang Li, Ningning Gao, et al.. (2015). Toll‐Like Receptor 7 Inactive Ligands Enhanced Cytokine Induction by Conjugation to Weak Antigens. ChemMedChem. 10(6). 977–980. 12 indexed citations
17.
Wang, Xiaodong, Dong Gao, Yu Liu, et al.. (2015). Antitumor activity of a novel small molecule TLR7 agonist via immune response induction and tumor microenvironment modulation. Oncology Reports. 35(2). 793–800. 9 indexed citations
18.
Gao, Dong, Yu Liu, Wang Li, et al.. (2014). Synthesis and immunoregulatory activities of conjugates of a Toll-like receptor 7 inert ligand. Bioorganic & Medicinal Chemistry Letters. 24(24). 5792–5795. 1 indexed citations
19.
Jin, Guangyi, Desheng Lu, Shiyin Yao, et al.. (2008). Amide derivatives of ethacrynic acid: Synthesis and evaluation as antagonists of Wnt/β-catenin signaling and CLL cell survival. Bioorganic & Medicinal Chemistry Letters. 19(3). 606–609. 33 indexed citations
20.
Jin, Guangyi, Christina Wu, Dennis A. Carson, & Howard B. Cottam. (2006). Guanosine analog in the pyrido[2,3-d]pyrimidine ring system As a potential Toll-like receptor agonist. Nucleosides Nucleotides & Nucleic Acids. 25(12). 1391–1397. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Huan Nie Breakdown of academic impact, for papers by Joanna Rossowska Breakdown of academic impact, for papers by Somesh Sharma Breakdown of academic impact, for papers by Hanjie Yu Breakdown of academic impact, for papers by Danuta Duś Breakdown of academic impact, for papers by Salvatore Di Maro Breakdown of academic impact, for papers by Renée Mosi Breakdown of academic impact, for papers by Stefanie C. Fas Breakdown of academic impact, for papers by Iva Ugrinova Breakdown of academic impact, for papers by Srujan Marepally
Rankless by CCL
2026